Business Wire

BRENMILLER-ENERGY

4.11.2022 12:01:48 CET | Business Wire | Press release

Share
Enel and Brenmiller Energy Inaugurate “TES”, an Innovative Rock-Based Storage System in Tuscany, Italy

The Enel Group and Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy”; TASE: BNRG, Nasdaq: BNRG), inaugurated today an innovative, sustainable energy storage system in Santa Barbara, Tuscany, in the municipality of Cavriglia (province of Arezzo), in the presence of the President of the Region of Tuscany Eugenio Giani, the Mayor of Cavriglia Leonardo Degl’Innocenti o Sanni, Ambassador-Designate of Israel to Italy Alon Bar, Head of Enel Green Power and Thermal Generation at Enel Salvatore Bernabei, Chief Innovability® Officer of Enel Ernesto Ciorra and Chairman and CEO of Brenmiller Energy, Avi Brenmiller.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221104005085/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Enel and Brenmiller's first-of-its-kind Thermal Energy Storage (“TES”) system at the Santa Barbara power plant in Tuscany, Italy (Photo: Business Wire)

The goal of this Thermal Energy Storage (“TES”) project is to build an innovative thermal storage system in Santa Barbara, which is completely sustainable and capable of accelerating the energy transition. The integration of the TES system with the existing power plant enables Enel and Brenmiller to test the technology in the field, in challenging operating conditions and on a large scale. The system offers reduced power plant start-up times and greater speed in load variations, which are necessary performance requirements to enable the efficient use of renewable energy. The system can be used to store excess energy produced from renewable sources in the form of heat to offer decarbonization services to industrial customers and to integrate long-term storage solutions with renewable plants.

Brenmiller Energy developed the technology in Israel and supplied the storage system; Enel integrated the system with its Santa Barbara power plant and helped to validate its performance in a real environment.

The TES technology utilizes a two-stage charge and discharge process to provide thermal energy. During the charging phase, steam produced by the Santa Barbara facility passes through pipes to heat adjacent crushed rocks; during the discharging phase, the accumulated heat is released to heat pressurized water and generate steam for electricity. This first-of-its-kind TES system can store up to 24MWh of clean heat at a temperature of about 550°C for five hours, providing critical resiliency to the power plant.

“Flexibility and adequacy are two fundamental components of an efficient and reliable electricity system, which can be supplied more and more efficiently by storage,” said Salvatore Bernabei, Head of Enel Green Power and Thermal Generation at Enel. "This trial allows us to validate a family of innovative and sustainable technologies in the segment of long-term storage, which will allow for an ever greater integration of renewables into the grid."

“This solution makes renewables more reliable, flexible and resilient and can be used to decarbonize sectors that need heat at high temperatures,” said Ernesto Ciorra, Director of Innovability® of Enel. “Furthermore, it does not involve any use of rare materials and can be made using stones available in every part of the planet, so it is scalable in a sustainable way everywhere. We thank the colleagues of the Tel Aviv hub for having found it and our Italian colleagues for having implemented it, thanks also to the financial support deriving from the collaboration between the Italian and Israeli governments.”

Our TES system at Enel’s Santa Barbara power plant in Tuscany is the first-ever system of its kind to provide utility-scale thermal energy storage and offers commercial and industrial users a viable path towards decarbonization,” said Avi Brenmiller, Chairman and CEO of Brenmiller Energy. “The TES also makes it possible to add additional renewables to the grid with greater reliability. We believe the success of this moment reflects the types of innovative collaborations needed to transition the global economy away from its heavy, albeit lessening, dependence on fossil fuels, and towards a 100% clean, flexible, and affordable energy grid.”

Eugenio Giani, President of the Region of Tuscany, said: “This inauguration confirms that Tuscany has a central role for energy, both for production and for innovation. Welcoming sustainability today means doing good for the environment, attracting investments and creating value, which is why we are particularly happy with Enel's choice to test here in Santa Barbara, which has always been a land of work and ingenuity, new technologies that can be applied on a scale. world. Tuscany is already one of the most virtuous Italian regions with over 50% of self-produced energy from renewable sources and an important research and innovation fabric, today we take a new step into the future with the hope that it will be a further contribution to overcome the energy crisis."

"Today we are celebrating a successful Italian-Israeli cooperation experience thanks to which Italy will benefit from an innovative made-in-Israel solution for energy storage," said the Ambassador-Designate of Israel in Italy, Alon Bar. "A technology that stands out in the international search for clean energy solutions to face the current global energy crisis. The Brenmiller Energy-Enel partnership takes the form of a continuation of the commitment made by the Israeli Embassy in promoting the collaboration protocol between the Israel Innovation Authority and Enel signed in 2015. This makes us particularly happy and enthusiastic in continuing to help these companies to thrive."

The collaboration between Enel and Brenmiller came about as part of an Italian-Israeli collaboration protocol aimed at accelerating cooperation between Israeli companies and large Italian industries. The project was partly financed by the Israeli Innovation Authority, which supported Brenmiller with 1 million euros in financing.

About Enel

Enel, which celebrates its 60th anniversary this year, is a multinational power company and a leading integrated player in the global power and renewables markets. At global level, it is the largest renewable private player, the foremost network operator by number of end users and the biggest retail operator by customer base. The Group is the worldwide demand response leader and the largest European utility by ordinary EBITDA [1]. Enel is present in 30 countries worldwide, producing energy with around 92 GW of total capacity. Enel Grids, the Group’s global business line dedicated to the management of the electricity distribution service worldwide, delivers electricity through a network of around 2.3 million kilometers to more than 75 million end users. The Group brings energy to around 70 million homes and businesses. Enel’s renewables arm Enel Green Power has a total capacity of around 55 GW and a generation mix that includes wind, solar, geothermal, and hydroelectric power, as well as energy storage facilities, installed in Europe, the Americas, Africa, Asia, and Oceania. Enel X Global Retail, Enel's global business line active in the areas of energy supply and efficiency, has a total capacity of around 7.9 GW of demand response managed globally and has installed 62 MW of behind-the-meter storage capacity. In addition, Enel X Way is the Group’s new company fully dedicated to electric mobility, managing more than 380,000 public and private EV charging points worldwide, both directly and through interoperability agreements. [1] Enel’s leadership in the different categories is defined by comparison with competitors’ FY 2021 data. Publicly owned operators are not included.

About Brenmiller Energy Ltd.

Brenmiller Energy delivers scalable thermal energy storage solutions and services that allow customers to cost-effectively decarbonize their operations. Its patented bGen thermal storage technology enables the use of renewable energy resources, as well as waste heat, to heat crushed rocks to very high temperatures. They can then store this heat for minutes, hours, or even days before using it for industrial and power generation processes. With bGen, organizations have a way to use electricity, biomass and waste heat to generate the clean steam, hot water and hot air they need to mold plastic, process food and beverages, produce paper, manufacture chemicals and pharmaceuticals or drive steam turbines without burning fossil fuels. For more information visit the company’s website at https://bren-energy.com/ and follow the company on Twitter and LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the potential benefits and capabilities of the Company’s TES system, the goals of the TES project in Santa Barbara, the sustainable qualities and capabilities of the TES system, including the possibility to store excess energy so that it is available when needed as well as to add additional renewables to the grid with greater reliability, and that the TES can become a powerful enabler for the electrification of industrial thermal consumption. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company's results include, but are not limited to, the Company’s planned level of revenues and capital expenditures, the demand for and market acceptance of our products, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks and the risks associated with the adequacy of existing cash resources. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's prospectus dated May 24, 2022 filed with the U.S. Securities and Exchange Commission ("SEC"), which is available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005085/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye